Categories AlphaGraphs, Earnings, Technology

Salesforce posts strong Q4 results; Global expansion on track

Cloud computing company Salesforce posted solid revenue growth along with a better-than-expected profit for its fourth quarter of 2018. Revenues for fiscal year 2018 were also up 25% year-over-year, above estimates. The company also raised its outlook for fiscal year 2019.

The stock slightly moved up shortly after the release of the strong results.

The San Francisco-based company saw strength in its cloud service offerings. Although Salesforce exceeded market estimates in subscriptions and support, it failed to meet them in professional services.

Unlike its competitors Microsoft and Oracle, Salesforce is unencumbered by non-cloud solutions, which in turn has helped it retain many customers.  The company is also working on developing tailor-made products for its customers to keep up with its competitors. This system has posted solid increases.

Salesforce is increasing its focus on global expansion to achieve its annual revenue target of $20 billion by 2021. However, the expansion to countries such as the UK, Canada and Japan has led to higher costs. Despite this, the company saw strong revenue growth in Europe, which is now its fastest-growing region. Salesforce also saw solid growth in Asia and the company remains optimistic on these two regions.

During the quarter, Salesforce entered into a strategic partnership with Google to combine its customer relations management platform with G Suite and Google Analytics. The company also strengthened its existing partnership with IBM. Salesforce.com earnings results

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top